IP Library Granted Patent US 10,901,237
Granted Patent B2
US 10,901,237 · App. 15/876,595 · Granted Jan 26, 2021

Ophthalmic lens with an optically non-coaxial zone for myopia control

Inventors: Noel A. Brennan (Jacksonville, FL); Xu Cheng (St. Johns, FL); Jaclyn V. Hernandez (Jacksonville, FL); Michael J. Collins (Jollys Lookout, AU); Brett A. Davis (Holland Park, AU); Fan Yi (Stafford Heights, AU); Derek Dean Nankivil (Jacksonville, FL)
Assignee: Johnson & Johnson Vision Care, Inc.
G02C7/044A61F2/1451A61F2/1613G02C7/048G02C7/06A61F2002/1696A61F2230/0065G02C2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,901,237
App. No.
15/876,595
Granted
Jan 26, 2021
Kind
B2
Abstract

The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising an ADD power, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone.

Claims (31)

1. An ophthalmic lens for at least one of slowing, retarding or preventing myopia progression, the ophthalmic lens comprising:

a center zone with a negative power for myopic vision correction; and

at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising a positive power relative to the center zone, the at least one treatment zone having a surface shape projecting outwardly from a front surface of said ophthalmic lens and comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone, wherein the at least one treatment zone has an annular configuration sharing a common geometric axis with the center zone, and wherein the surface shape of the at least one treatment zone causes light passing therethough to form a focal ring in front of the retina with infinite focal points, with the locus of each of the infinite focal points on the ring being non-coaxial from the geometric axis of the center zone.

2. The ophthalmic lens of claim 1 , wherein the portion of the generally toroidal shape may be derived from a torus (e.g., a spheroidal torus), after making a slice in the shape of the surface of a right circular cone through the surface of the spheroidal torus wherein the principal axis of the cone is coincident with the axis of rotation about which the torus is generated.

3. The ophthalmic lens according to claim 1 , wherein the at least one treatment zone is configured to minimize generation of a focal point behind a retinal plane of the eye of a wearer.

4. The ophthalmic lens according to claim 1 , further comprising a transition zone disposed between then center zone and the at least one treatment zone such that the at least one treatment zone, the transition zone, and the center zone form a continuous surface.

5. The ophthalmic lens according to claim 1 , wherein the at least one treatment zone comprises an ADD power relative to the myopia correction power of greater than +0.50 D.

6. The ophthalmic lens according to claim 1 , wherein the at least one treatment zone comprises an optical power from about −10.00 D to about +15.00 D.

7. The ophthalmic lens according to claim 1 , wherein a diameter of the center zone is about 2 mm to about 7 mm.

8. The ophthalmic lens according to claim 1 , wherein the at least one treatment zone has an outer margin at about 4.5 mm from a center of the lens.

9. The ophthalmic lens according to claim 1 , wherein a halo effect is minimized.

10. The ophthalmic lens according to claim 1 , wherein the ophthalmic lens comprises a contact lens.

11. The ophthalmic lens according to claim 1 , wherein the ophthalmic lens comprises a spectacle lens.

12. The ophthalmic lens according to claim 1 , wherein the ophthalmic lens comprises an intraocular lens, a corneal inlay, or a corneal onlay.

13. The ophthalmic according to claim 1 , further comprising one or more stabilization mechanisms.

14. An ophthalmic lens for at least one of slowing, retarding or preventing myopia progression, the ophthalmic lens comprising:

a center zone with a negative power for myopic vision correction, the center zone having a principal axis orthogonal to a surface thereof and passing through a center of the ophthalmic lens; and

at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising a positive power relative to the center zone, the at least one treatment zone having a surface shape projecting outwardly from a front surface of said ophthalmic lens and comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone, and wherein the at least one treatment zone has a tilt angle configured to direct an innermost ray relative to a cross section of the treatment zone to cross the principal axis at a point that is at or anterior to a retinal plane of a wearer of the ophthalmic lens, wherein the at least one treatment zone has an annular configuration sharing a common geometric axis with the center zone, and wherein the surface shape of the at least one treatment zone causes light passing therethough to form a focal ring in front of the retina with infinite focal points, with the locus of each of the infinite focal points on the ring being non-coaxial from the geometric axis of the center zone.

15. The ophthalmic lens according to claim 14 , wherein the tilt angle is configured to direct the innermost ray to cross the principal axis at a point between the retinal plane and a point on the principal axis that represents a coincident point focus of the treatment zone.

16. The ophthalmic lens of claim 14 , wherein the portion of the generally toroidal shape may be derived from a torus (e.g., a spheroidal torus), after making a slice in the shape of the surface of a right circular cone through the surface of the spheroidal torus wherein the principal axis of the cone is coincident with the axis of rotation about which the torus is generated.

17. The ophthalmic lens according to claim 14 , further comprising a transition zone disposed between then center zone and the at least one treatment zone such that the at least one treatment zone, the transition zone, and the center zone form a continuous surface.

18. The ophthalmic lens according to claim 14 , wherein the at least one treatment zone comprises an ADD power relative to myopia correction power of greater than +5.00 D.

19. The ophthalmic lens according to claim 14 , wherein the at least one treatment zone comprises an optical power from about −10.00 D to about +15.00 D.

20. The ophthalmic lens according to claim 19 , wherein the tilt angle is dependent upon the optical power of the treatment zone.

21. The ophthalmic lens according to claim 14 , wherein a diameter of the center zone is about 3 mm to about 7 mm.

22. The ophthalmic lens according to claim 14 , wherein the at least one treatment zone has an outer margin at about 4.5 mm from a center of the lens.

23. The ophthalmic lens according to claim 14 , wherein a halo effect is minimized.

24. The ophthalmic lens according to claim 14 , wherein the ophthalmic lenses comprises a contact lens.

25. The ophthalmic lens according to claim 14 , wherein the ophthalmic lenses comprises a spectacle lens.

26. The ophthalmic lens according to claim 14 , wherein the ophthalmic lens comprises an intraocular lens, a corneal inlay, or a corneal onlay.

27. The ophthalmic according to claim 14 , further comprising one or more stabilization mechanisms.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2018
From: NANKIVIL, DEREK DEAN
To: JOHNSON & JOHNSON VISION CARE, INC.
Reel/Frame 046963/0173 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2018
From: BRENNAN, NOEL A.; CHENG, XU; HERNANDEZ, JACLYN V.; COLLINS, MICHAEL J.; DAVIS, BRETT A.; YI, FAN
To: JOHNSON & JOHNSON VISION CARE, INC.
Reel/Frame 045503/0929 →
Continuity (1)
Related Publication 20190227342A1 · Jul 25, 2019
Cited By (3)
US 1,111,076 US 1,120,998 US 12,631,905